ArticleThe Neurohospitalist2014
Neurocysticercosis.
Article in The Neurohospitalist, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.
- Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Guideline
- Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).The American journal of tropical medicine and hygiene · 2018Guideline
- Comparative analysis of parenchymal and extraparenchymal neurocysticercosis: a 10-year experience from northern Thailand.BMC infectious diseases · 2026Article
- When Appearances Deceive: A Case Report of Neurocysticercosis Masquerading As Tuberculoma.Cureus · 2026Article
- Article
- Unravelling parasitic spinal infections: a narrative review on diagnosis, treatment strategies, and collaborative management approaches.GMS hygiene and infection control · 2026Review
- First report of adult Taenia solium in human brain with neurocysticercosis: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
- Obstructive hydrocephalus: when subarachnoid cysts alert to the challenging diagnosis of neurocysticercosis.Quantitative imaging in medicine and surgery · 2025Article
- Disseminated Neurocysticercosis With Intraventricular and Cisternal Extension Without Hydrocephalus: A Case Report.Clinical case reports · 2025Article
- The hidden threat of cysticercosis: A neglected public health problem.Open veterinary journal · 2025Review
- Giant Neurocysticercosis: A Rare Medical Condition.Cureus · 2024Article
- Neurocysticercosis Presenting as Migraine in the United States.The American journal of case reports · 2024Article
- Neurocysticercosis: unwinding the radiological conundrum.Polish journal of radiology · 2024Article
- Endoscopic endonasal approach for isolated subarachnoid neurocysticercosis in basal cisterns and its complications: illustrative case.Journal of neurosurgery. Case lessons · 2022Article
- Improved Diagnosis of Viable Parenchymal Neurocysticercosis by Combining Antibody Banding Patterns on Enzyme-Linked Immunoelectrotransfer Blot (EITB) with Antigen Enzyme-Linked Immunosorbent Assay (ELISA).Journal of clinical microbiology · 2022Article
- Article
- Granulomas in parasitic diseases: the good and the bad.Parasitology research · 2020Review
- Modelling heme-mediated brain injury associated with cerebral malaria in human brain cortical organoids.Scientific reports · 2019Article
- Headaches More Common among Epilepsy Sufferers with Neurocysticercosis than Other Structural Brain Lesions.Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health · 2017Article
- Performance of Tsol-p27 antigen for the serological diagnosis of cysticercosis in Mozambique.Journal of helminthology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurocysticercosis, the most common helminthic infection of the nervous system, is a major cause of acquired epilepsy worldwide. The disease occurs when humans become intermediate hosts of the tapeworm Taenia solium after ingesting its eggs by contagion from an asymptomatic Taenia carrier. Within the nervous system, parasites may locate in brain parenchyma, subarachnoid space, ventricular system, or spinal cord, causing several pathological changes that are responsible for the clinical pleomorphism of the disease. Seizures are the most common clinical manifestation, but a sizable proportion of patients develop focal deficits, intracranial hypertension, or cognitive decline. Preoperative diagnosis of neurocysticercosis is possible after proper integration of data from neuroimaging studies and immunological tests. Cysticidal drugs (albendazole and praziquantel) have changed the prognosis of most patients with neurocysticercosis. The use of these drugs has shown to reduce the parasite load within the central nervous system and to improve the clinical prognosis of the disease in many cases. Future studies should focus on disease eradication through the implementation of control programs against all the interrelated steps in the life cycle of T solium, including human carriers of the adult tapeworm, infected pigs, and eggs in the environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.